Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Insulin may not be the culprit in poorer outcomes, according to TUXEDO sub-study.
Read More »Stenting Risks For Insulin-Treated Diabetes Patients
Eran Bashan Part 3, About Patients on Basal Bolus Therapy
In part 3 of this Exclusive Interview, Eran Bashan, CEO of Hygieia, explains about managing patients on basal bolus therapy.
Read More »What is the Actual Cost of Insulin for Your Patients?
For patients in the U.S., the price of this lifesaving treatment has risen dramatically.
Read More »Eran Bashan Part 2, A d-Nav Demo in the UK
In part 2 of this Exclusive Interview, Steve Freed, DIC publisher, learns about the results of a d-Nav demonstration in the UK where they saw a 2-point drop in A1C.
Read More »Connection Between Nicotine and Diabetes
Why smokers have an increased risk of type 2.
Read More »Eran Bashan Part 1, An Overview of d-Nav
In part 1 of this Exclusive Interview, Eran Bashan explains d-Nav, an automated solution for insulin management that tailors the insulin regimen to the individual needs of the patient.
Read More »Effectiveness of Insulin Regimens For Patients With Uncontrolled Type 2 Diabetes
Use of degludec/liraglutide vs glargine injections focus of study.
Read More »Clinical Opportunities for Biosimilar Insulins
What will be the impact of the new biosimilar insulins now in development?
Read More »Reprogramming Human Skin Cells to Produce Insulin
Conversion to pancreatic cells may lead to new cell replacement therapies.
Read More »Create Safe Environment for Your Patients to Tell You the Truth
A teenage type 1 on an insulin pump was seen in our office for follow up. The download on her pump revealed some interesting numbers. First off, her glucose levels were out of target range and secondly her I:CHO ratio and her insulin sensitivity looked more like the numbers of a type 2 diabetic vs a type 1. Her I:CHO was 1:16 and her insulin sensitivity was 1:30. In my experience, I'm used to seeing a lower I:CHO and a higher insulin sensitivity in type 1 vs type 2.
Read More »